BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li M, Cai J, Han X, Ren Y. Downregulation of circNRIP1 Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-211-5p/HOXC8 Axis. Cancer Manag Res 2020;12:9159-71. [PMID: 33061608 DOI: 10.2147/CMAR.S268872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Najafi S. The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review. J Cancer Res Clin Oncol 2022. [PMID: 36053324 DOI: 10.1007/s00432-022-04328-z] [Reference Citation Analysis]
2 Chen L, Wang J, Liu Q. Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer. Front Cell Dev Biol 2022;10:999174. [DOI: 10.3389/fcell.2022.999174] [Reference Citation Analysis]
3 Fu L, Huo J, Fitrat H, Kong Y, Zhang L, Shang C, Li G, Ji F, Fu X, Qiu X, Ding X. CircNRIP1 Exerts Oncogenic Functions in Papillary Thyroid Carcinoma by Sponging miR-653-5p and Regulating PBX3 Expression. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/2081501] [Reference Citation Analysis]
4 Han Y, Zhao G, Shi X, Wang Y, Wen X, Zhang L, Guo X. The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications. Front Pharmacol 2022;13:885075. [DOI: 10.3389/fphar.2022.885075] [Reference Citation Analysis]
5 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
6 Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samsami M. Emerging role of circular RNAs in the pathogenesis of ovarian cancer. Cancer Cell Int 2022;22:172. [PMID: 35488239 DOI: 10.1186/s12935-022-02602-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ke N, Chen L, Liu Q, Xiong H, Chen X, Zhou X. Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the GDNF-LIF Interaction. Front Oncol 2022;12:848733. [PMID: 35311096 DOI: 10.3389/fonc.2022.848733] [Reference Citation Analysis]
8 Li C, Zhu L, Fu L, Han M, Li Y, Meng Z, Qiu X. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Diagn Pathol 2021;16:93. [PMID: 34689819 DOI: 10.1186/s13000-021-01153-9] [Reference Citation Analysis]
9 Li G, Gong J, Cao S, Wu Z, Cheng D, Zhu J, Huang X, Tang J, Yuan Y, Cai W, Zhang H. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance. Front Oncol 2021;11:742149. [PMID: 34660304 DOI: 10.3389/fonc.2021.742149] [Reference Citation Analysis]
10 Foruzandeh Z, Zeinali-Sehrig F, Nejati K, Rahmanpour D, Pashazadeh F, Seif F, Alivand MR. CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review. Cell Mol Biol Lett 2021;26:41. [PMID: 34556024 DOI: 10.1186/s11658-021-00284-7] [Reference Citation Analysis]
11 D'Ambrosi S, Visser A, Antunes-Ferreira M, Poutsma A, Giannoukakos S, Sol N, Sabrkhany S, Bahce I, Kuijpers MJE, Oude Egbrink MGA, Griffioen AW, Best MG, Koppers-Lalic D, Oudejans C, Würdinger T. The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:4644. [PMID: 34572871 DOI: 10.3390/cancers13184644] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lan H, Yuan J, Zeng D, Liu C, Guo X, Yong J, Zeng X, Xiao S. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer. Front Genet 2021;12:693259. [PMID: 34512721 DOI: 10.3389/fgene.2021.693259] [Reference Citation Analysis]
13 Liu Z, Li M. Circular RNAs and their role in renal cell carcinoma: a current perspective. Cancer Cell Int 2021;21:469. [PMID: 34488780 DOI: 10.1186/s12935-021-02181-7] [Reference Citation Analysis]
14 Fontemaggi G, Turco C, Esposito G, Di Agostino S. New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer. Cancers (Basel) 2021;13:3154. [PMID: 34202482 DOI: 10.3390/cancers13133154] [Reference Citation Analysis]
15 Wang B, Yin H, Zhang H, Wang T. circNRIP1 facilitates keloid progression via FXR1‑mediated upregulation of miR‑503‑3p and miR‑503‑5p. Int J Mol Med 2021;47:70. [PMID: 33649815 DOI: 10.3892/ijmm.2021.4903] [Reference Citation Analysis]